At our labs in Seoul, we have microbiological, immunological, genomic containment, as well as animal facilities and teams with expertise in molecular biology, microbial genetics, bioinformatics, and immunology. We discover new vaccines, improve existing vaccines, and  evaluate non-clinical performance and safety in promising vaccine candidates to reduce risk in clinical development.